Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- Vial is a tech-native CRO offering faster,cheaper clinical trial execution through their proprietary technology platform,targeting biotech sponsors with…
- Coverage: Global · Phase I–III
- Therapeutic focus: Dermatology, Ophthalmology, Oncology, Gastroenterology
- Scale: Small,Medium
Company fit
Best suited for
Biotech startups wanting tech-forward,cost-efficient CRO services
Study fit
Best suited for biotech startups wanting tech-forward,cost-efficient cro services.
Core strengths
- Tech-native CRO model
- Competitive pricing
- Transparent processes
Considerations
- Young company (founded 2020)
- Limited Phase III track record
Key facts
- Category
- EDC / eClinical
- Geography
- Global
- Studies managed
- 40
- HQ
- United States
Publications
Reviewed vendor articles, separate from independent ratings.
Browse the publications library